Eupraxia Pharmaceuticals Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -88 | -73 | -62 |
EBITDA | -12,640 | -16,637 | -6,306 |
EBIT | -15,736 | -16,709 | -6,369 |
Net Income | -12,653 | -16,711 | -6,361 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -10,328 | -10,074 | -3,274 |
Cash | 58,500 | 80,563 | 88,959 |
Basic Shares | 56,712 | 51,939 | 36,915 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -331 | -163 | -209 | -193 |
EBITDA | -38,348 | -24,967 | -20,783 | -17,860 |
EBIT | -38,586 | -25,139 | -20,900 | -18,007 |
Net Income | -38,576 | -25,502 | -21,248 | -18,489 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,627 | -30,098 | -15,677 | -14,630 |
Cash | 80,563 | 33,101 | 14,562 | 24,727 |
Basic Shares | 39,956 | 33,930 | 24,146 | 19,285 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.23 |
2026-03-31 | -$0.23 |
2025-12-31 | -$0.37 |
2025-09-30 | -$0.19 |